Blue Trust’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Other funds holding SRPT
Blue Trust's SRPT Position: Q2 2026 in Review
Blue Trust sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 18 shares — an estimated $392 sold.
Blue Trust first reported a position in SRPT in Q2 2022 and held it in 13 quarters. The position peaked at $89.7K in Q3 2024. 326 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.
- Blue Trust reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
- Blue Trust sold 18 Sarepta Therapeutics shares in Q2 2026, an estimated $392.
- Blue Trust first reported a position in Sarepta Therapeutics in Q2 2022 and held it in 13 quarters.
- Blue Trust's Sarepta Therapeutics position peaked at $89.7K in Q3 2024.
- 326 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.
Based on Blue Trust's 13F filing for Q2 2026, filed 21 Jul 2026.